Lifecore Biomedical Inc (NASDAQ: LFCR) stock enjoyed a major increase of 11.2% on 8/13/24. The shares closed at $6.04. However, below average trading volume at 82% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 14.8% during the last week.
Current PriceTarget Research Rating
LFCR’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Lifecore Biomedical is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment